HD Buzz update

A new imaging tool means that scientists can now directly measure the levels of the toxic huntingtin protein in animal models of Huntington’s disease. HD Buzz explain

Change to office hours

Due to the current weather emergency in South East Queensland our staff will not be in the office for the next few days. We are of course available via phone or email, so please leave a message and we will contact you as soon as possible. Stay safe everyone!

Study into ehealth literacy

Researchers at Edith Cowan University are undertaking a research study investigating health literacy and ehealth literacy in individuals living with neurological conditions and caregivers. The information gathered from this study will help to understand whether health information is being communicated appropriately for people living with neurological conditions. If you would like to participate please visit […]

Support groups suspended

Due to the current Omicron Covid outbreak, we are suspending all ‘in person’ Support groups during February for the safety of our clients and staff. We hope to resume again in March. Our staff are of course still available if you need support or have questions. We will also be holding an extra ZOOM chat […]

Roche announce new Phase II clinical trial

Following the disappointing news in March last year that Roche’s highly anticipated drug trial for the HD drug tominersen would be abandoned, we’ve had a more promising start to 2022! Roche has just announced that they will be starting a new Phase II clinical trial into the drug, which they say appears to have some […]